Register entry
- Registered sites
- 1
- Active NDC listings
- 27
- Live patents
- 0
- Countries
- 1
- Base
- Mexico
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Sicor de Mexico S.A. de C.V. | Av. San Rafael No. 35, Parque Industrial Lerma, Lerma, Estado de Mexico C.P 52000, Mexico (MEX) | Analytical testing, Active ingredient (API) manufacture | 3002808102811287556 |
Catalogue
Drug listings by form and route
2727 active NDC listings: 27 bulk ingredient. By marketing category: BULK INGREDIENT 27.
| Dosage form | NDCs |
|---|---|
| powder | 27 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| sicor de mexico s.a. de c.v | 27 |
Catalogue
Marketed products
27| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | 5-Fluorouracil | powder | 63592-0500BULK INGREDIENT |
| - | Abiraterone Acetate | powder | 63592-4520BULK INGREDIENT |
| - | Afatinib Dimaleate | powder | 63592-0355BULK INGREDIENT |
| - | Alclometasone Dipropionate | powder | 63592-0316BULK INGREDIENT |
| - | Amcinonide | powder | 63592-0177BULK INGREDIENT |
| - | Azacitidine | powder | 63592-1800BULK INGREDIENT |
| - | Aztreonam Anhydrous | powder | 63592-0180BULK INGREDIENT |
| - | Budesonide | powder | 63592-0187BULK INGREDIENT |
| - | Carboplatin | powder | 63592-0271BULK INGREDIENT |
| - | Docetaxel Anhydrous | powder | 63592-0360BULK INGREDIENT |
| - | Erlotinib Hydrochloride | powder | 63592-3400BULK INGREDIENT |
| - | Erlotinib Hydrochloride | powder | 63592-3407BULK INGREDIENT |
| - | Fluticasone Furoate | powder | 63592-3370BULK INGREDIENT |
| - | Fluticasone Propionate Micronized | powder | 63592-0335BULK INGREDIENT |
| - | Gemcitabine Hydrochloride | powder | 63592-4075BULK INGREDIENT |
| - | Letrozole | powder | 63592-3376BULK INGREDIENT |
| - | Lifitegrast | powder | 63592-3385BULK INGREDIENT |
| - | Medroxyprogesterone Acetate | powder | 63592-0089BULK INGREDIENT |
| - | Megestrol Acetate | powder | 63592-0109BULK INGREDIENT |
| - | Mometasone Furoate | powder | 63592-0387BULK INGREDIENT |
| - | Mometasone Furoate | powder | 63592-0397BULK INGREDIENT |
| - | Nintedanib Esylate | powder | 63592-7200BULK INGREDIENT |
| - | Olodaterol HCl | powder | 63592-7600BULK INGREDIENT |
| - | Oxaliplatin | powder | 63592-0700BULK INGREDIENT |
| - | Prednicarbate | powder | 63592-2140BULK INGREDIENT |
| - | Ribociclib Succinate | powder | 63592-1600BULK INGREDIENT |
| - | Rocuronium Bromide | powder | 63592-0178BULK INGREDIENT |
Neighbours
Registered in the same town
3- Bayer Healthcare Manufacturing SrlLerma, MEX
- Grimann SA de CVLerma, MEX
- Iron Lab SA de CVLerma, MEX
Compare
Comparable companies in Mexico
- Avon Cosmetics Manufacturing, S. de R.L. de C.V.1 site · 16 NDC
- Holiday Labs Mexico, S.A. de C.V.1 site · 15 NDC
- Interquim, S.A. de C.V.1 site · 14 NDC
- Bayer de Mexico, S.A. de C.V.1 site · 10 NDC
- Signa S.A. de C.V.1 site · 9 NDC
- Nouryon Chemicals, S.A. de C.V1 site · 8 NDC
- Laboratorios Imperiales, S.A. de C.V.1 site · 7 NDC
- Laboratorios Zeyco SA de CV1 site · 5 NDC
- Fermic, S.A. de C.V.1 site · 4 NDC
- Boehringer Ingelheim Promeco S.A. de C.V.1 site · 3 NDC
Enquiry
Common questions
- Is Sicor de Mexico S.A. de C.V. FDA approved?
- Sicor de Mexico S.A. de C.V. holds 1 FDA-registered establishment in Mexico. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Sicor de Mexico S.A. de C.V.'s drugs manufactured?
- The FDA register lists Lerma. Registered operations: analytical testing, active ingredient (API) manufacture.
- What drugs does Sicor de Mexico S.A. de C.V. make?
- 27 products are listed under Sicor de Mexico S.A. de C.V. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.